Search for: "TEVA PHARMACEUTICALS, INC."
Results 61 - 80
of 838
Sort by Relevance
|
Sort by Date
30 Mar 2022, 7:56 am
Vizio, Inc., 2022 WL 885771 (Fed. [read post]
9 Mar 2022, 2:06 pm
These anticipated 2022 settlements include the $420 million Teva Pharmaceutical settlement; the $175 million Luckin Coffee settlement; the $129 million Granite Construction settlement; and the $100 million Stamps.com settlement. [read post]
24 Feb 2022, 8:23 pm
Teva Pharmaceuticals USA, Inc., the panel majority affirming a District Court decision that the claimed invention was indeed obvious. [read post]
14 Feb 2022, 9:38 am
Teva Pharmaceuticals USA, Inc., 18-1976 (Fed. [read post]
25 Jan 2022, 3:11 pm
There have already been several significant settlements that appear positioned for court approval in 2022, including Twitter ($809.5 million); Teva Pharmaceutical Industries ($420 million); Luckin Coffee ($175 million); Granite Construction ($129 million); Novo Nordisk A/S ($100 million); Stamps.com ($100 million) and NCI Building Systems, Inc. ($100 million). [read post]
18 Jan 2022, 2:29 pm
” Upon paying the settlement amount, Endo and two of its subsidiaries, Endo Pharmaceuticals Inc. and Endo Health Solutions Inc., will fully resolve Florida’s pending opioid-related claims. [read post]
13 Jan 2022, 9:01 am
The landmark New York State opioid trial reached its conclusion on Dec. 30, 2021 after the jury found drugmaker Teva Pharmaceuticals and distributor Anda Inc. liable for helping to fuel the nation’s two-decade-long opioid crisis. [read post]
7 Jan 2022, 12:56 pm
In a significant development in the ongoing effort to assess blame and responsibility for the opioid epidemic, which has led to the deaths of hundreds of thousands of individuals and ravaged communities throughout the United States, on December 30th, after a six-month trial, a New York jury found that Teva Pharmaceuticals USA, Inc. [read post]
7 Jan 2022, 12:56 pm
In a significant development in the ongoing effort to assess blame and responsibility for the opioid epidemic, which has led to the deaths of hundreds of thousands of individuals and ravaged communities throughout the United States, on December 30th, after a six-month trial, a New York jury found that Teva Pharmaceuticals USA, Inc. [read post]
23 Dec 2021, 8:48 pm
One such decision arose earlier this month when the Federal Circuit affirmed a determination of non-obviousness by the Patent Trial and Appeal Board in an inter partes review proceeding, that opinion captioned Teva Pharmaceuticals USA, Inc. v. [read post]
16 Dec 2021, 12:15 pm
She recommended that Teva and its subsidiaries receive 50 percent of liability and Anda, Inc., the other 50 percent. [read post]
7 Dec 2021, 6:37 pm
by Dennis Crouch Teva Pharmaceuticals, LLC v. [read post]
7 Dec 2021, 8:33 am
Inc. v. [read post]
1 Dec 2021, 6:22 am
The main defendants at issue in the Elmiron litigation include Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson Pharmaceuticals, Inc.), Teva Branded Pharmaceutical Products R&D, Inc., and Teva Pharmaceuticals USA, Inc. [read post]
1 Dec 2021, 6:22 am
The main defendants at issue in the Elmiron litigation include Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson Pharmaceuticals, Inc.), Teva Branded Pharmaceutical Products R&D, Inc., and Teva Pharmaceuticals USA, Inc. [read post]
1 Dec 2021, 6:22 am
The main defendants at issue in the Elmiron litigation include Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson Pharmaceuticals, Inc.), Teva Branded Pharmaceutical Products R&D, Inc., and Teva Pharmaceuticals USA, Inc. [read post]
7 Nov 2021, 9:31 am
The defendants included Johnson & Johnson, Teva Pharmaceutical Industries, Endo International and AbbVie Inc. [read post]
28 Oct 2021, 7:40 am
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
28 Oct 2021, 7:40 am
While it was Judge Maltese’s court-commissioned report on APKS that grabbed media attention in recent weeks, the New York trial continues against remaining defendants Allergan Finance (a subsidiary of AbbVie Inc.), Teva Pharmaceutical Industries Ltd. and Anda, Inc. [read post]
21 Oct 2021, 9:50 am
For more details on any of the previous weeks in the New York opioid trial, visit past coverage: New York Opioid Trial Begins With Opening Arguments “Gremlins” Analogy Nets National Headlines New York Agrees to $1.18 Billion Settlement With Three Major Distributors Local Officials, First Responders Testify in New York Opioid Trial New York State Files Motion for Default Judgment Endo Pharmaceuticals Agrees to Settlement Remaining defendants in the trial include Teva… [read post]
